Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic

Alpha 1 Antitrypsin deficiency (AATD) is a hereditary condition characterized by low serum Alpha 1 Antitrypsin (AAT) levels and a predisposition towards early-onset emphysema. Infusion of AAT is the only disease-modifying therapy that can sufficiently raise plasma AAT levels above the putative prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Herth, Felix J F, Sandhaus, Robert A, Turner, Alice M, Sucena, Maria, Welte, Tobias, Greulich, Timm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570922/
https://www.ncbi.nlm.nih.gov/pubmed/34754184
http://dx.doi.org/10.2147/COPD.S325211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570922/
https://www.ncbi.nlm.nih.gov/pubmed/34754184
http://dx.doi.org/10.2147/COPD.S325211

Ejemplares similares